Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12497615rdf:typepubmed:Citationlld:pubmed
pubmed-article:12497615lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:12497615lifeskim:mentionsumls-concept:C0028768lld:lifeskim
pubmed-article:12497615lifeskim:mentionsumls-concept:C1333254lld:lifeskim
pubmed-article:12497615lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:12497615pubmed:issue1lld:pubmed
pubmed-article:12497615pubmed:dateCreated2002-12-23lld:pubmed
pubmed-article:12497615pubmed:abstractTextObsessive-compulsive disorder (OCD) is a frequent and disabling anxiety disorder. Dopamine (DA) might be involved in its pathophysiology, therefore DA receptors are candidate genes in OCD. A 48-base pairs (bp) polymorphism located in the third exon of the dopamine receptor type 4 (DRD4) gene has been described. Previous case control studies, however, have reported inconclusive results in OCD. The aim of the study was to study this polymorphism in a family-based association study of 55 trios. Extended transmission-disequilibrium test (ETDT) for preferential allele transmission in this group showed an absence of transmission of the allele 2 for the 48 bp repeat polymorphism of the DRD4 gene (P = 0.005). Moreover, in a population-based association study, we found a significantly lower frequency of the allele 2 in patients suffering from OCD compared to ethnically-matched controls (P = 0.02). We found no association of DRD4 48 bp polymorphism with OCD in the subgroup of patients with comorbid tics. This study is the first to report on a significant association of variants of the DRD4 gene in OCD, found on both family- and population-based studies. The results suggest that the 2 allele or a nearby genetic variation could have a protective effect against OCD symptoms.lld:pubmed
pubmed-article:12497615pubmed:languageenglld:pubmed
pubmed-article:12497615pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12497615pubmed:citationSubsetIMlld:pubmed
pubmed-article:12497615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12497615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12497615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12497615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12497615pubmed:statusMEDLINElld:pubmed
pubmed-article:12497615pubmed:monthJanlld:pubmed
pubmed-article:12497615pubmed:issn1552-4841lld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:LeboyerMarion...lld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:ChabaneNadiaNlld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:BourdelMarie-...lld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:PoirierMarie-...lld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:MilletBrunoBlld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:KrebsMarie-Od...lld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:LooHenriHlld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:DelormeRichar...lld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:LeroySophieSlld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:Mouren-Simeon...lld:pubmed
pubmed-article:12497615pubmed:authorpubmed-author:RouillonFréde...lld:pubmed
pubmed-article:12497615pubmed:copyrightInfoCopyright 2003 Wiley-Liss, Inc.lld:pubmed
pubmed-article:12497615pubmed:issnTypePrintlld:pubmed
pubmed-article:12497615pubmed:day1lld:pubmed
pubmed-article:12497615pubmed:volume116Blld:pubmed
pubmed-article:12497615pubmed:ownerNLMlld:pubmed
pubmed-article:12497615pubmed:authorsCompleteYlld:pubmed
pubmed-article:12497615pubmed:pagination55-9lld:pubmed
pubmed-article:12497615pubmed:dateRevised2008-5-21lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:meshHeadingpubmed-meshheading:12497615...lld:pubmed
pubmed-article:12497615pubmed:year2003lld:pubmed
pubmed-article:12497615pubmed:articleTitleAssociation between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder.lld:pubmed
pubmed-article:12497615pubmed:affiliationINSERM E0117 Paris V, University Department of Psychiatry, Sainte-Anne Hospital, Paris, France. millet@chsa.broca.inserm.frlld:pubmed
pubmed-article:12497615pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12497615pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12497615lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12497615lld:pubmed